ISSN: 2072-1439

Journal Home

Journal Guideline

Journal of Thoracic Disease Q2 Unclaimed

Pioneer Bioscience Publishing Company (PBPC) Hong Kong

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Thoracic Disease is a journal indexed in SJR in Pulmonary and Respiratory Medicine with an H index of 88. It has an SJR impact factor of 0,651 and it has a best quartile of Q2. It has an SJR impact factor of 0,651.

Journal of Thoracic Disease focuses its scope in these topics and keywords: aortic, treatment, pulmonary, hypertension, chronic, failure, role, lung, valve, respiratory, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pulmonary and Respiratory Medicine (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,651

SJR Impact factor

88

H Index

663

Total Docs (Last Year)

2138

Total Docs (3 years)

21272

Total Refs

4721

Total Cites (3 years)

1898

Citable Docs (3 years)

1.91

Cites/Doc (2 years)

32.08

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Annals of Allergy, Asthma and Immunology Q2
Journal of Asthma and Allergy Q2
Current Opinion in Pulmonary Medicine Q2
Chronic Obstructive Pulmonary Diseases Q2
Neurobiology of Sleep and Circadian Rhythms Q2

Compare this journals

Aims and Scope

Best articles by citations

RASSF1A methylation, YAP1 activation and metastasis: a new role for an old foe in lung cancer

Clinical outcomes for multi- and extensively drug resistant tuberculosis patients with adjunctive resectional lung surgery in Beijing, China

Clinical implications of discrepant results between genotypic MTBDRplus and phenotypic Lowenstein-Jensen method for isoniazid or rifampicin drug susceptibility tests in tuberculosis patients

Learning curve and established phase for uniportal VATS lobectomies: the Papworth experience

Neutrophils dominate the immune landscape of non-small cell lung cancer

Off-pump coronary artery bypass grafting (OPCABG) - a 'personal' European perspective

Off-pump coronary artery bypass grafting in high-risk patients: a review

Arterial events in cancer patients - the case of acute coronary thrombosis

Off-pump coronary artery bypass grafting in left main stem stenosis: outcomes, concerns and controversies

Off-pump coronary artery bypass grafting in octogenarians

Diagnostic value of KL-6 in idiopathic interstitial pneumonia

Hybrid extracorporeal membrane oxygenation

SHOW MORE ARTICLES

Predicting spread through air spaces (STAS) preoperatively: can imaging help?

Off-pump coronary artery bypass grafting: where are we now?

Why anti-PD1/PDL1 therapy is so effective? Another piece in the puzzle

Ideal conditions to perform EBUS-TBNA

The role of surgical intervention in lung cancer with carcinomatous pleuritis

Current outcomes of off-pump coronary artery bypass grafting: evidence from real world practice

Current outcomes of off-pump versus on-pump coronary artery bypass grafting: evidence from randomized controlled trials

Qualitative and quantitative imaging features of pulmonary subsolid nodules: differentiating invasive adenocarcinoma from minimally invasive adenocarcinoma and preinvasive lesions

The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomy

European perspective in Thoracic surgery - eso-coloplasty: when and how?

Bicaval dual lumen cannula in adult veno-venous extracorporeal membrane oxygenation - clinical pearls for safe cannulation

European perspectives in Thoracic Surgery, the ESTS venous thromboembolism (VTE) working group